Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Congenica, a UK-based patient genomic testing service provider based on research from Wellcome Sanger Institute and the UK’s National Health Service (NHS), has raised a series C extension from venture capital firm QVentures. The size of the additional financing has not been disclosed. Congenica raised $50m in an initial tranche featuring Cambridge Innovation Capital and Parkwalk Advisors in November 2020. Internet group Tencent and insurance provider Legal & General co-led the first close, which also attracted Xeraya Capital, Puhua Capital, IDO Investments and Downing Ventures.
TechsoMed, US-based tissue imaging technology developer backed by Technion – Israel Institute of Technology, completed a $7m series B round on Wednesday led by Axil Capital. The round included Johnson & Johnson Innovation – JJDC, the strategic investment arm of medical products group Johnson & Johnson, as well as Yongjin Capital, Cobro Ventures, Magna Capital Partners, NextLeap Ventures and Radianx Capital. It came in the wake of $2.6m from Technion’s Alfred Mann Institute, JJDC, semiconductor technology producer Screen Holdings, NextLeap Ventures and Axil Capital in mid-2019.
Elastrin, a US-based developer of therapeutics to render calcified tissue and organs supple again, has raised an undisclosed amount of financing from Kizoo Technology Capital. Elastrin is based on research at Clemson University and co-founder Prof Naren Vyavahare now serves as chief scientific officer.
– Additional reporting by Robert Lavine
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
